Business Standard

Tuesday, December 24, 2024 | 02:53 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

F&O Call: Nandish Shah recommends to long Glenmark Pharma futures

The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.

Markets, stocks, buy, sell, trading, shares, stock market
Premium

Nandish Shah Mumbai
Derivative recommendation on Glenmark Pharma

Buy Glenmark Jan Future at Rs 436
Stop Loss: Rs 427
Target: Rs 450 
Lot Size: 1,450
Approx margin required: Rs 1,33,000

Rationale:
  • We have seen long build up in the Glenmark Futures during the January series till now, where we have seen 2 per cent addition (Prov) in Open Interest with price rising by 3 per cent.
     
  • Short term trend of the stock is positive as stock price is trading above its 11 and 20 day EMA.
     
  • Primary trend of the stock is positive as stock price is trading above its 100 and 200 day EMA.
     
  • Momentum Oscillators like RSI (11)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in